Real world data are necessary to detect and anticipate innovative treatments quickly and efficiently based on ‘big data’ analyses (machine learning, data mining pattern detection). A platform with all stakeholders to prepare tangible ‘value based’ cases, based on outcome indicators and real world based data, can contribute to a broader support among all stakeholders and, in the longer term, more efficient care.
Participants: Representatives of careproviders, patients’ platforms, pharma industry, hospitals, insurancs and sickness funds, health authorities, policymakers, researchers (academic, foundations, corporate).
16:00 Intro by Pieter Van Herck
16:05 RWD in decision making (learning from COVID19 to strategic vision) – Jo De Cock
16:25 Short Q&A
16:30 RWE for regulatory and HTA decision-making: learning by doing – Ashley Jaksa
1) Status of RWE guidance and standards
2) Learn by doing approach - what we can learn from historical uses cases and current demonstration projects
16:50 Tour de table - open and moderated discussion
In 2020-2021, Shake the Disease focuses on health objectives as a basis for health policy making. Can a series of thematic brainstorms with stakeholders provide an impetus with necessary policy input? This will be developed in a series of 5 closed brainstorms, of which this is the first.
Jo De Cock is CEO of the National Institute of Health and Disability Insurance (NIHDI) since 1995. He has obtained a master of law and a master of criminology from the Catholic University of Louvain, where he started his professional experience as a research assistant on the Institute of Social Security on the Faculty of Law (1977-1983). He continued his career by joining the Center for political, economic and social studies where he was researcher and political advisor. From the mid-eighties until the beginning of the nineties he worked as a deputy director and counselor of social affairs in the office of the Belgian Prime Minister (1985-1993). Later on he filled the position of adjunct general administrator of the National Social Security Office (1993-1995). Jo De Cock is member of the board of directors of KCE (Belgian Health Care Knowledge Center) and a VUB Fellow.
Ashley Jaksa, MPH, is Vice President of Science at Aetion. Her role focuses on forming partnerships with regulatory and HTA agencies to enhance their use of RWE, use RWE to support their decision-making, and set methodological guidance for RWE generation. She also works with Aetion’s biopharma clients on using RWE in their HEOR and Market Access strategy. Previously, she led analytic services at Context Matters where she consulted with biopharma clients on designing and executing analytic projects. She also previously worked to curate HTA and regulatory decisions for Context Matters’ web based subscription platform. She has presented her research at numerous international conferences including ISPOR, HTAi and AMCP. She holds a bachelor's degree from the University of Michigan-Ann Arbor and a MPH from Yale University.
Er zijn nog geen foto's toegevoegd voor dit event.